Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and/or non-pregnant, non-lactating or postmenopausal females, between 18 and 55 years of age with a body mass index ≥ 19 and ≤ 30 kg/m2.~2. All subjects biologically capable of having children must agree and commit to the use acceptable method(s) of birth control.~Exclusion Criteria:~1. ECG abnormalities or lab values greater than 2 times the upper limit of normal.~2. Positive test results for human immunodeficiency virus (HIV), hepatitis B (HBsAg), or hepatitis C (IgG).~3. Positive urine test results for drugs of abuse or history of drug/alcohol abuse.~4. Use of marijuana, illicit drugs or nicotine-containing products.~5. Donated or had significant loss of whole blood.~6. Taken any prescription or nonprescription drugs, vitamins, minerals, or dietary/herbal supplements.~7. History of abdominal and/or pelvic surgery, cholecystectomy, gastric bypass or gastric band surgery, or cardiothoracic surgery.~8. History of anxiety, tension, agitation, psychiatric disorders, psychosis, or depression requiring hospitalization, psychotherapy, and/or medication.~9. History of acute or chronic gastrointestinal disease or any condition that may interfere with the absorption, distribution, metabolism or excretion of the study treatment.~10. History of seizures or diagnosis of epilepsy or other seizure disorder.~11. History or laboratory evidence of bleeding or clotting disorder or condition.~12. History or laboratory evidence of malignancy, stroke, diabetes, cardiac, renal, liver, and chronic pulmonary disease.~13. Have or have a history of hay fever or seasonal allergies requiring over-the-counter or prescription medications.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- COV155 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).